MetLife Inc. stock holds near 52-week high as analysts lift targets

Published on 09/21/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife Inc. stock traded around USD 97.08 on September 18, 2026 on the NYSE, close to its 52-week high of USD 100.93 and implying a market capitalization of about USD 62.47 billion. Analysts see further upside with an average 12-month target of USD 102.77 as of September 20, 2026.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund — Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. stock (ISIN US59156R1086) traded at USD 97.08 on the New York Stock Exchange on September 18, 2026, keeping the life insurer close to its 52-week high of USD 100.93 and giving it a market capitalization of about USD 62.47 billion as investors weigh updated analyst targets and dividend income potential.

Analysts lift MetLife targets

According to MarketBeat on September 18, 2026, MetLife shares closed at USD 97.08 on the NYSE, down 0.28% from the prior session and modestly below the average 12-month analyst price target of USD 102.77 as compiled in the same period.

As Yahoo Finance reported using September 18, 2026 data, Morgan Stanley maintained its Overweight rating on MetLife while raising its price target from USD 103.00 to USD 111.00 on August 24, 2026, and Wells Fargo lifted its target from USD 101.00 to USD 109.00, both moves reinforcing the view that the stock offers upside from the high USD 90 range.

Stock trades near 52-week high

Per an overview cited by ad hoc news on September 20, 2026, MetLife stock traded at USD 97.08 on September 18, 2026, placing it close to its 52-week high of USD 100.93 and implying a market capitalization of about USD 62.47 billion based on that price.

The same ad hoc news report highlighted that at USD 97.08, MetLife shares are trading roughly 4% below the 52-week high of USD 100.93 while still above the average 12-month analyst target of USD 102.77, suggesting investors have already priced in a significant part of the expected growth yet leaving some room for further gains if earnings and cash flows track forecasts.

Closing price and investor perspective

As of the completed trading session on September 18, 2026, MetLife Inc. stock closed at USD 97.08 on the NYSE, within a 52-week range that extends up to USD 100.93, and at that level the company carried a market capitalization of about USD 62.47 billion based on exchange data for that date.